Kenvue CEO Discusses Growth Outlook After J&J Unit Jumps 20% in Market Debut
Johnson & Johnson's consumer-health unit Kenvue made its debut on the New York Stock Exchange and jumped about 20% on Thursday. Thibaut Mongon, CEO of Kenvue, joined Cheddar News to discuss business growth goals and what lies ahead for its well-known pipeline of products, including Band-Aid, Neutrogena, Tylenol, among others.
Matthew Frankel, certified financial planner and contributing analyst with The Motley Fool, joined Cheddar News to discuss what the IRS' guidance is on state stimulus payments.
Nick Hanigan, Executive Director & Development Manager at Paspaley Pearls Properties, joins Cheddar News' Hena Doba on a Walk and Talk to check out The Wall Street Hotel's latest innovations in the heart of the historic financial district.
Wall Street closed higher as traders made their final moves in anticipation of a report that could show whether inflation is cooling in the right way or setting the market up for worse pain.
